SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014992
Filing Date
2023-04-27
Accepted
2023-04-27 07:09:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A itos-defa14a-2023.2.htm DEFA14A 20431
2 GRAPHIC img122548300_0.jpg GRAPHIC 736588
3 GRAPHIC img122548300_1.jpg GRAPHIC 478216
  Complete submission text file 0000950170-23-014992.txt   1694125
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39401 | Film No.: 23851838
SIC: 2836 Biological Products, (No Diagnostic Substances)